Clinical trial
Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure
NCT03998735 is registered in ClinicalTrials.gov with Masonic Cancer Center, University of Minnesota as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Nornicotine in Smokeless Tobacco as a Precursor for Carcinogen Exposure
- Lead sponsor
- Masonic Cancer Center, University of Minnesota
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- October 19, 2021
- Completion date
- August 31, 2026
- Enrollment
- 55 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
smokeless tobacco